Publicacións (14) Publicacións de Laura Villaverde Piñeiro

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Evaluación de riesgos en el manejo de equipos para Point-of-Care Testing de ámbito hospitalario. Revisión sistemática

    Medicina & Laboratorio, Vol. 27, Núm. 4, pp. 297-313

  3. Intravenous and topical sodium thiosulfate for treatment of non-uremic calciphylaxis

    Piel

  4. Medication experience and patient's related needs in chronic myeloid leukemia treated with tyrosine kinase inhibitors: Systematic review

    Farmacia Hospitalaria, Vol. 47, Núm. 2, pp. 85-92

  5. Off-label use of guselkumab for pyoderma gangrenosum

    Medicina Clinica

  6. Risk assessment of Point-of-Care Testing equipment in the hospital environment. Systematic review

    Medicina y Laboratorio, Vol. 27, Núm. 4, pp. 297-313

  7. Thoughts on the shortage of vinflunine: Could we have done more?

    European Journal of Hospital Pharmacy

2022

  1. Addressing the at-home care needs of patients with multidrug-resistant bacteria: What should we do?

    European Journal of Hospital Pharmacy

  2. Capecitabine: Guaranteed access in adjuvant treatment of breast cancer

    European Journal of Hospital Pharmacy

  3. Defining a new term: Defensive hospital pharmacy practices

    European Journal of Hospital Pharmacy

  4. Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines

    European Journal of Hospital Pharmacy

2020

  1. Síndrome de Marfan de presentación atípica, reflejo de una nueva mutación

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 5, Núm. 2, pp. 87-89

2019

  1. Nonalpine epithelioid angiosarcoma of the thyroid in an old woman

    Medicina Clinica

2018

  1. Paralysis of the external popliteal sciatic nerve associated with daptomycin administration

    Journal of Clinical Pharmacy and Therapeutics, Vol. 43, Núm. 4, pp. 578-580